Your CBD Legal Questions Answered

Can we legally buy and consume marijuana in France today? Yes and no. Yes, due to the fact that the state has unwinded its guidelines on CBD, consisting of through the Minister of Health. And no, at the same time, due to the fact that only products containing cannabidiol (CBD), an active compound that does not have the psychedelic results attributed to THC, are considered legal. Let us analyze what is legal and what is not with regard to marijuana and CBD.

CBD is legal in France, but THC is not

Cannabis must not be confused with cannabidiol. Particularly because the 2nd is legal in certain forms in France … While the other is not! Since cannabidiol (understood by the acronym provision CBD) is just among the many active compounds from the hemp plant, which does not have the psychedelic results of its cousin THC – the one that makes you “stone”.

Simply put, what is typically called “marijuana”, which includes high concentrations of THC (tetrahydrocannabinol) is still considered a narcotic product. And therefore illegal in France as in lots of nations on earth. On the other hand, marijuana which gives pride of place to the cannabinoid referred to as cannabidiol, it is legal as long as its THC levels do not exceed 0.2%.

Nevertheless, the legislation remains vague in France on this subject. Presently, there is no law that makes it clear whether midnight CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in an electric cigarette. However it is also found in other forms (consisting of oil or paste), without its purchase and intake being reprehensible … To attempt to make it basic, let’s state that CBD is not restricted by French law, unlike THC

CBD vs THC.

Although CBD and THC are indistinguishable, they are really different. These are the very best understood of the 500 cannabinoids found in hemp. And each has its particular results. THC is especially understood for its psychedelic residential or commercial properties: it causes a change in the state of awareness by acting straight on the brain. By taking in marijuana rich in THC, we “hover”: well-being, ecstasy, relaxation … But also red eyes, dilated pupils and, sometimes, anxiety or perhaps fear.

CBD has nothing to do with it. It is not blissful. It does not trigger anxiety or anxiety attacks. On the contrary: cannabidiol is in the process of making its method by virtue of its beneficial therapeutic results. CBD assists eliminate discomfort and swelling, decrease anxiety, reduce the suffering of victims of anxiety attacks and depression, and even deal with certain illness (such as epilepsy or Alzheimer’s). In addition, it has a really low toxicity and presents (nearly) no addicting danger, even if the absence of clinical research studies lowers these qualities to mere hypotheses.

Legalization of CBD in France: should we go even more?

Certainly, the legal progress regarding CBD is positive, but whatever remains to be done. The health ministry wants to be cautious, and the government’s position on the matter looks like a balancing act. At the same time, the National Medicines Agency has clearly spoken up. We therefore look after the goat and the cabbage so as not to get too included, while the vaporized cannabidiol has been available in France for a few years already, benefiting from the legal uncertainty that persists.

Beyond the 0.2% THC threshold licensed in marketed products, it must be kept in mind that only the liquid form of CBD (meant for smokeless cigarettes) is really legal. The purchase and intake of resin or cigarette smoking herb is therefore not regulated, especially because the THC level is typically higher (around 15%). In addition, only using seeds and fibers is licensed in France. However what about CBD oil, which allows you to delight in the benefits of the compound without exposing your lungs to potentially hazardous smoke? What about CBD paste? On these topics, there is radio silence.

In addition, CBD is considered a “dietary supplement”, which forbids providing it as a medication. And make it an enlightened ad for users and clients. Too bad, due to the fact that, in the meantime, lots of prospective beneficiaries are not benefiting from it. It is therefore needed to go even more and clarify things: more than a concern of consumer welfare, it refers public health.

Scroll to top